8 research outputs found
Vaccinium ciliatum Thunb.
原著和名: アラゲナツハゼ科名: ツツジ科 = Ericaceae採集地: 京都府 宮津市 成相山 (丹後 宮津市 成相山)採集日: 1983/7/19採集者: 萩庭丈壽整理番号: JH005817国立科学博物館整理番号: TNS-VS-955817備考: DB作成協力会による補足あ
Additional file 2: of LYL1 gene amplification predicts poor survival of patients with uterine corpus endometrial carcinoma: analysis of the Cancer genome atlas data
Figure S2. Enriched genes of cancer-related and cell proliferation pathways according to the two histologic types; serous and endometrioid. (PNG 486Â kb
Additional file 2: of M1 macrophage recruitment correlates with worse outcome in SHH Medulloblastomas
Table S1. List of antibodies used for immunohistochemistry and immunofluorescence assay Table S2. Correlation between TAM and other prognostic factors estimated with a logistic regression in SHH MB. (DOCX 17Â kb
Additional file 1: of M1 macrophage recruitment correlates with worse outcome in SHH Medulloblastomas
Figure S1. Macrophage recruitment in human tonsil FFPE tissue. Figure S2. Expression heatmap of 22 subgroup-specific signature genes in 48 study patients by the nanoString nCounter System. Figure S3. TAM recruitment and prognostic outcomes in the whole patient cohort. Figure S4. TAM recruitment and prognostic outcomes in SHH MB from Yonsei University. (PPTX 3883Â kb
Additional file 2: of LYL1 gene amplification predicts poor survival of patients with uterine corpus endometrial carcinoma: analysis of the Cancer genome atlas data
Figure S2. Enriched genes of cancer-related and cell proliferation pathways according to the two histologic types; serous and endometrioid. (PNG 486Â kb
Additional file 1: of LYL1 gene amplification predicts poor survival of patients with uterine corpus endometrial carcinoma: analysis of the Cancer genome atlas data
Figure S1. Gene set enrichment analysis according to histologic types and TCGA classes. (PNG 144Â kb
Additional file 1: Table S1. of Efficient strategy for the molecular diagnosis of intractable early-onset epilepsy using targeted gene sequencing
List of 172 targeted genes included in the epilepsy panel. Table S2. Clinical and demographic information of the patients. Table S3. Quality control matrices of NGS test results for all patients in this study. Table S4. Diagnostic yield of targeted NGS according to types of epilepsy syndrome. Table S5. Clinical factors associated with genetic abnormalities. (XLSX 31 kb